AtriCure Ebit vs Selling General Administrative Analysis

ATRC Stock

USD 23.37 0.20 0.86%

AtriCure financial indicator trend analysis is way more than just evaluating AtriCure prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AtriCure is a good investment. Please check the relationship between AtriCure Ebit and its Selling General Administrative accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

Ebit vs Selling General Administrative

Ebit vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AtriCure Ebit account and Selling General Administrative. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between AtriCure's Ebit and Selling General Administrative is -0.52. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of AtriCure, assuming nothing else is changed. The correlation between historical values of AtriCure's Ebit and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of AtriCure are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Ebit i.e., AtriCure's Ebit and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.52

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Ebit

Selling General Administrative

Most indicators from AtriCure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.78, whereas Enterprise Value Over EBITDA is projected to grow to (95.86).

	2021	2022	2023	2024 (projected)
Gross Profit	205.9M	245.9M	297.4M	312.3M
Total Revenue	274.3M	330.4M	399.2M	419.2M

Gross Profit Total Revenue

AtriCure fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Inventory	Other Current Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total
Total Assets		0.96	-0.95	0.39	0.84	0.97	0.77	0.93	0.93	0.84	0.81	0.86	0.85	0.85	0.88	0.9	0.5	0.98	0.67	0.89	0.83	0.84	0.66	0.75	0.94	0.96
Total Stockholder Equity	0.96		-0.93	0.26	0.81	0.99	0.57	0.94	0.95	0.89	0.89	0.92	0.9	0.81	0.9	0.9	0.32	0.92	0.77	0.84	0.9	0.82	0.43	0.8	0.94	0.91
Retained Earnings	-0.95	-0.93		-0.27	-0.87	-0.97	-0.71	-0.94	-0.95	-0.88	-0.83	-0.89	-0.86	-0.89	-0.91	-0.92	-0.43	-0.92	-0.71	-0.84	-0.89	-0.89	-0.56	-0.79	-0.93	-0.94
Other Assets	0.39	0.26	-0.27		0.25	0.26	0.57	0.08	0.1	-0.04	0.06	0.08	0.05	0.25	0.03	0.07	0.38	0.33	-0.12	0.66	-0.06	0.23	0.63	-0.06	0.46	0.29
Common Stock Shares Outstanding	0.84	0.81	-0.87	0.25		0.83	0.71	0.76	0.77	0.68	0.58	0.65	0.63	0.99	0.76	0.78	0.51	0.84	0.45	0.7	0.68	0.99	0.52	0.51	0.74	0.8
Other Stockholder Equity	0.97	0.99	-0.97	0.26	0.83		0.62	0.96	0.97	0.91	0.89	0.93	0.91	0.84	0.92	0.92	0.35	0.93	0.77	0.85	0.92	0.85	0.48	0.82	0.95	0.94
Total Liab	0.77	0.57	-0.71	0.57	0.71	0.62		0.58	0.56	0.41	0.33	0.43	0.41	0.72	0.54	0.6	0.78	0.81	0.18	0.7	0.39	0.7	0.97	0.33	0.64	0.76
Other Current Liab	0.93	0.94	-0.94	0.08	0.76	0.96	0.58		0.99	0.95	0.91	0.95	0.95	0.78	0.92	0.92	0.29	0.9	0.81	0.75	0.95	0.79	0.44	0.89	0.9	0.92
Total Current Liabilities	0.93	0.95	-0.95	0.1	0.77	0.97	0.56	0.99		0.97	0.93	0.97	0.97	0.78	0.93	0.92	0.24	0.88	0.82	0.76	0.97	0.8	0.4	0.9	0.91	0.9
Accounts Payable	0.84	0.89	-0.88	-0.04	0.68	0.91	0.41	0.95	0.97		0.94	0.98	0.98	0.69	0.93	0.91	0.09	0.8	0.88	0.62	0.98	0.72	0.26	0.95	0.81	0.81
Cash	0.81	0.89	-0.83	0.06	0.58	0.89	0.33	0.91	0.93	0.94		0.98	0.97	0.59	0.87	0.84	-0.04	0.73	0.91	0.7	0.97	0.63	0.2	0.95	0.87	0.77
Inventory	0.86	0.92	-0.89	0.08	0.65	0.93	0.43	0.95	0.97	0.98	0.98		0.99	0.66	0.91	0.89	0.1	0.8	0.91	0.72	0.98	0.69	0.3	0.96	0.89	0.84
Other Current Assets	0.85	0.9	-0.86	0.05	0.63	0.91	0.41	0.95	0.97	0.98	0.97	0.99		0.64	0.9	0.88	0.05	0.79	0.88	0.68	0.97	0.68	0.28	0.96	0.86	0.81
Common Stock	0.85	0.81	-0.89	0.25	0.99	0.84	0.72	0.78	0.78	0.69	0.59	0.66	0.64		0.79	0.81	0.5	0.84	0.45	0.72	0.69	0.99	0.53	0.53	0.76	0.81
Property Plant Equipment	0.88	0.9	-0.91	0.03	0.76	0.92	0.54	0.92	0.93	0.93	0.87	0.91	0.9	0.79		1.0	0.27	0.87	0.79	0.65	0.93	0.8	0.4	0.89	0.81	0.87
Property Plant And Equipment Net	0.9	0.9	-0.92	0.07	0.78	0.92	0.6	0.92	0.92	0.91	0.84	0.89	0.88	0.81	1.0		0.34	0.9	0.75	0.67	0.91	0.81	0.47	0.86	0.81	0.89
Net Debt	0.5	0.32	-0.43	0.38	0.51	0.35	0.78	0.29	0.24	0.09	-0.04	0.1	0.05	0.5	0.27	0.34		0.59	-0.06	0.4	0.09	0.46	0.79	-0.02	0.31	0.6
Non Current Assets Total	0.98	0.92	-0.92	0.33	0.84	0.93	0.81	0.9	0.88	0.8	0.73	0.8	0.79	0.84	0.87	0.9	0.59		0.61	0.79	0.78	0.83	0.71	0.69	0.86	0.95
Non Currrent Assets Other	0.67	0.77	-0.71	-0.12	0.45	0.77	0.18	0.81	0.82	0.88	0.91	0.91	0.88	0.45	0.79	0.75	-0.06	0.61		0.48	0.92	0.49	0.07	0.88	0.7	0.69
Cash And Short Term Investments	0.89	0.84	-0.84	0.66	0.7	0.85	0.7	0.75	0.76	0.62	0.7	0.72	0.68	0.72	0.65	0.67	0.4	0.79	0.48		0.64	0.72	0.62	0.57	0.96	0.82
Net Receivables	0.83	0.9	-0.89	-0.06	0.68	0.92	0.39	0.95	0.97	0.98	0.97	0.98	0.97	0.69	0.93	0.91	0.09	0.78	0.92	0.64		0.72	0.23	0.95	0.83	0.83
Common Stock Total Equity	0.84	0.82	-0.89	0.23	0.99	0.85	0.7	0.79	0.8	0.72	0.63	0.69	0.68	0.99	0.8	0.81	0.46	0.83	0.49	0.72	0.72		0.51	0.58	0.77	0.81
Non Current Liabilities Total	0.66	0.43	-0.56	0.63	0.52	0.48	0.97	0.44	0.4	0.26	0.2	0.3	0.28	0.53	0.4	0.47	0.79	0.71	0.07	0.62	0.23	0.51		0.22	0.53	0.66
Property Plant And Equipment Gross	0.75	0.8	-0.79	-0.06	0.51	0.82	0.33	0.89	0.9	0.95	0.95	0.96	0.96	0.53	0.89	0.86	-0.02	0.69	0.88	0.57	0.95	0.58	0.22		0.77	0.74
Total Current Assets	0.94	0.94	-0.93	0.46	0.74	0.95	0.64	0.9	0.91	0.81	0.87	0.89	0.86	0.76	0.81	0.81	0.31	0.86	0.7	0.96	0.83	0.77	0.53	0.77		0.89
Short Long Term Debt Total	0.96	0.91	-0.94	0.29	0.8	0.94	0.76	0.92	0.9	0.81	0.77	0.84	0.81	0.81	0.87	0.89	0.6	0.95	0.69	0.82	0.83	0.81	0.66	0.74	0.89

Click cells to compare fundamentals

AtriCure Account Relationship Matchups

AtriCure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	557.9M	714.5M	615.3M	585.4M	613.9M	644.6M
Total Stockholder Equity	247.3M	412.4M	483.8M	456.8M	466.2M	489.5M
Retained Earnings	(282.2M)	(330.4M)	(280.2M)	(326.6M)	(357.1M)	(339.2M)
Other Assets	705K	16.5M	955K	2.0M	1.0	0.95
Common Stock Shares Outstanding	37.6M	42.1M	46.0M	45.7M	46.3M	24.2M
Liabilities And Stockholders Equity	557.9M	714.5M	615.3M	585.4M	613.9M	644.6M
Other Stockholder Equity	529.7M	742.4M	764.8M	787.4M	824.2M	865.4M
Total Liab	310.5M	302.1M	131.6M	128.7M	147.8M	80.4M
Other Current Liab	32.8M	28.0M	36.1M	33.0M	44.7M	46.9M
Total Current Liabilities	49.9M	49.1M	56.4M	58.4M	74.6M	78.3M
Accounts Payable	14.9M	12.7M	18.6M	19.9M	27.4M	28.7M
Cash	28.5M	41.9M	43.7M	58.1M	84.3M	88.5M
Inventory	29.4M	35.0M	39.0M	45.9M	67.9M	71.3M
Other Current Assets	3.9M	4.3M	5.0M	5.5M	8.6M	9.0M
Common Stock	40K	45K	46K	47K	48K	28.1K
Property Plant Equipment	32.6M	28.3M	36.2M	42.6M	49.0M	51.5M
Property Plant And Equipment Net	36.7M	30.2M	36.2M	42.6M	46.8M	49.1M
Net Debt	47.9M	32.1M	32.0M	11.0M	(9.8M)	(9.3M)
Non Current Assets Total	414.7M	407.8M	419.2M	370.2M	347.7M	365.1M
Non Currrent Assets Other	705K	440K	955K	2.0M	2.2M	2.3M
Cash And Short Term Investments	81.8M	244.2M	119.1M	121.1M	137.3M	144.1M
Net Receivables	28.0M	23.1M	33.0M	42.7M	52.5M	55.1M
Common Stock Total Equity	40K	45K	46K	47K	54.1K	28.2K
Non Current Liabilities Total	260.6M	253.0M	75.1M	70.3M	73.2M	60.0M
Property Plant And Equipment Gross	36.7M	30.2M	36.2M	42.6M	99.2M	104.1M
Total Current Assets	143.2M	306.7M	196.1M	215.2M	266.2M	279.6M
Accumulated Other Comprehensive Income	(158K)	312K	(948K)	(4.1M)	(993K)	(943.4K)
Short Long Term Debt Total	76.4M	74.0M	75.6M	69.1M	74.5M	78.2M
Long Term Debt	59.6M	53.4M	59.7M	56.8M	60.6M	63.6M
Short Term Investments	53.3M	202.3M	75.4M	63.0M	53.0M	40.8M
Short Term Debt	2.2M	8.4M	1.8M	5.5M	2.5M	2.5M
Intangible Assets	129.9M	128.2M	43.0M	39.3M	64.0M	36.9M
Other Liab	186.4M	187.4M	1.2M	1.2M	1.4M	1.3M
Net Tangible Assets	(117.3M)	49.4M	206.0M	182.6M	210.0M	220.5M
Retained Earnings Total Equity	(282.2M)	(330.4M)	(280.2M)	(326.6M)	(294.0M)	(308.7M)
Long Term Debt Total	59.6M	53.4M	59.7M	56.8M	65.4M	34.9M
Capital Surpluse	529.7M	742.4M	764.8M	787.4M	905.5M	470.9M
Non Current Liabilities Other	201.0M	199.6M	15.4M	13.5M	1.2M	1.2M

Pair Trading with AtriCure

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AtriCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will appreciate offsetting losses from the drop in the long position's value.

Moving together with AtriCure Stock

0.62

AHG

Akso Health Group

Pair Corr

Moving against AtriCure Stock

0.77	GCTK	GlucoTrack	Pair Corr
0.75	SNDA	Sonida Senior Living	Pair Corr
0.67	TNDM	Tandem Diabetes Care Buyout Trend	Pair Corr
0.66	JYNT	Joint Corp Financial Report 2nd of May 2024	Pair Corr
0.47	TLIS	Talis Biomedical Corp	Pair Corr

The ability to find closely correlated positions to AtriCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AtriCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AtriCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AtriCure to buy it.

The correlation of AtriCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AtriCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AtriCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for AtriCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:

How To Invest In AtriCure

Details

Is AtriCure Stock a good investment?

Details

What is AtriCure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites

Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.66)

Revenue Per Share

8.621

Quarterly Revenue Growth

0.21

Return On Assets

(0.03)

Return On Equity

(0.07)

The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AtriCure Ebit vs Selling General Administrative Analysis

Ebit vs Selling General Administrative

Ebit vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Ebit

Selling General Administrative

AtriCure fundamental ratios Correlations

AtriCure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AtriCure fundamental ratios Accounts

Pair Trading with AtriCure

Moving together with AtriCure Stock

Moving against AtriCure Stock

Complementary Tools for AtriCure Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Property Plant Equipment
Other Stockholder Equity	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Total Current Liabilities	+ 0.99	Other Current Liab
Other Current Assets	+ 0.99	Inventory

Other Stockholder Equity	- 0.97	Retained Earnings
Total Current Liabilities	- 0.95	Retained Earnings
Retained Earnings	- 0.95	Total Assets
Short Long Term Debt Total	- 0.94	Retained Earnings
Other Current Liab	- 0.94	Retained Earnings
Total Current Assets	- 0.93	Retained Earnings